Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q3 2022 vs. Q2 2022
How the institutions holding Fortress Biotech, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 66 | 1 | 64 | −1 |
| Shares | 30.8M | 7.63K | 30.1M | −753.1K (−2.4%) |
| Value | $25.9M | $6.00K | $25.8M | −$52.9K (−0.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Fortress Biotech, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Monticello Wealth Management, LLC | 100,000 | $86.0K | 0.01% |
| PVG Asset Management Corp | 95,500 | $82.1K | 0.32% |
| Arete Wealth Advisors, LLC | 52,547 | $26.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 14,080 | $12.0K | 0.00% |
| Cetera Investment Advisers | 13,033 | $11.0K | 0.00% |
| Spotlight Asset Group, Inc. | 10,700 | $7.00K | 0.01% |
| UBS Group AG | 2,141 | $2.00K | 0.00% |
| Axiom Investment Management LLC | 265 | $0 | 0.00% |
Sold out (9)
Institutions that held Fortress Biotech, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 236,569 | $199.0K |
| Susquehanna International Group, LLP | 94,005 | $79.0K |
| Y-Intercept (Hong Kong) Ltd | 28,370 | $24.0K |
| Engineers Gate Manager LP | 19,472 | $16.0K |
| Balyasny Asset Management LLC | 15,147 | $13.0K |
| Legal & General Group Plc | 5,803 | $5.00K |
| Citigroup Inc | 2,253 | $2.00K |
| Tower Research Capital LLC (TRC) | 2,159 | $2.00K |
| New York State Common Retirement Fund | 620 | $1.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Fortress Biotech, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Urban Wealth Management, LLC | 7,635 | $6.00K |